FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3024348737> ?p ?o ?g. }

• W3024348737 endingPage "513" @default.
• W3024348737 startingPage "506" @default.
• W3024348737 abstract "Community pharmacists are best placed to improve medication adherence because they frequently interact with patients and have been trained to manage medication-related problems. Therefore, it is essential to equip pharmacists adequately to detect non-adherent patients quickly and intervene to improve medication adherence. To design e-AdPharm, a tool that addresses unmet needs and barriers of community pharmacists to provide medication adherence support to patients with chronic diseases. A qualitative study using 4 focus group discussions with community pharmacists was conducted with a semi-structured interview guide and discussions lasting for 1–2 h. The discussions covered the barriers and needs of pharmacists related to medication adherence support provided to patients, their expectations of an electronic tool based on prescription refills to help them provide this support, and the design of the tool. Focus group data were coded and analyzed using an iterative process, with thematic and descriptive analyses. Twenty-six community pharmacists participated. Lack of time and motivation from pharmacists and patients were common barriers to the provision of medication adherence support. Accordingly, community pharmacists wished to measure medication adherence quickly, provide easily interpretable data to patients on their medication use, and raise the patient's awareness of non-adherence. The pharmacists expressed their need to have an electronic tool to share medication adherence information with the treating physician. Regarding the design of e-AdPharm, the pharmacists wanted a table displaying medication adherence with a color code representing adherence level. They also stressed the importance of a structured section enabling them to continuously document the interventions made and the need for patient follow-ups. e-AdPharm meet the needs and overcome the barriers of community pharmacists to provide medication adherence support to their patients. Future studies should examine the feasibility of implementing e-AdPharm in community pharmacies and test its efficacy for improving medication adherence." @default.
• W3024348737 created "2020-05-21" @default.
• W3024348737 creator A5010661200 @default.
• W3024348737 creator A5026295972 @default.
• W3024348737 creator A5062972768 @default.
• W3024348737 creator A5064007284 @default.
• W3024348737 creator A5071840675 @default.
• W3024348737 creator A5082328976 @default.
• W3024348737 creator A5085170235 @default.
• W3024348737 creator A5088405436 @default.
• W3024348737 date "2021-03-01" @default.
• W3024348737 modified "2023-10-03" @default.
• W3024348737 title "Development of an electronic tool (e-AdPharm) to address unmet needs and barriers of community pharmacists to provide medication adherence support to patients" @default.
• W3024348737 cites W1616484873 @default.
• W3024348737 cites W1741567663 @default.
• W3024348737 cites W1902532899 @default.
• W3024348737 cites W1909868681 @default.
• W3024348737 cites W1979290264 @default.
• W3024348737 cites W1989479869 @default.
• W3024348737 cites W1989620475 @default.
• W3024348737 cites W2037803098 @default.
• W3024348737 cites W2041256954 @default.
• W3024348737 cites W2047089452 @default.
• W3024348737 cites W2057112394 @default.
• W3024348737 cites W2058647728 @default.
• W3024348737 cites W2064936130 @default.
• W3024348737 cites W2067404301 @default.
• W3024348737 cites W2067425281 @default.
• W3024348737 cites W2068725670 @default.
• W3024348737 cites W2070893229 @default.
• W3024348737 cites W2086921502 @default.
• W3024348737 cites W2104611034 @default.
• W3024348737 cites W2113320440 @default.
• W3024348737 cites W2137665561 @default.
• W3024348737 cites W2147982456 @default.
• W3024348737 cites W2154926843 @default.
• W3024348737 cites W2167961448 @default.
• W3024348737 cites W2169305774 @default.
• W3024348737 cites W2171278250 @default.
• W3024348737 cites W2172312423 @default.
• W3024348737 cites W2196042012 @default.
• W3024348737 cites W2268668026 @default.
• W3024348737 cites W2319355471 @default.
• W3024348737 cites W2397791882 @default.
• W3024348737 cites W2811496043 @default.
• W3024348737 cites W51671479 @default.
• W3024348737 doi "https://doi.org/10.1016/j.sapharm.2020.04.022" @default.
• W3024348737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32402728" @default.
• W3024348737 hasPublicationYear "2021" @default.
• W3024348737 type Work @default.
• W3024348737 sameAs 3024348737 @default.
• W3024348737 citedByCount "5" @default.
• W3024348737 countsByYear W30243487372021 @default.
• W3024348737 countsByYear W30243487372022 @default.
• W3024348737 countsByYear W30243487372023 @default.
• W3024348737 crossrefType "journal-article" @default.
• W3024348737 hasAuthorship W3024348737A5010661200 @default.
• W3024348737 hasAuthorship W3024348737A5026295972 @default.
• W3024348737 hasAuthorship W3024348737A5062972768 @default.
• W3024348737 hasAuthorship W3024348737A5064007284 @default.
• W3024348737 hasAuthorship W3024348737A5071840675 @default.
• W3024348737 hasAuthorship W3024348737A5082328976 @default.
• W3024348737 hasAuthorship W3024348737A5085170235 @default.
• W3024348737 hasAuthorship W3024348737A5088405436 @default.
• W3024348737 hasConcept C104863432 @default.
• W3024348737 hasConcept C126322002 @default.
• W3024348737 hasConcept C144024400 @default.
• W3024348737 hasConcept C144133560 @default.
• W3024348737 hasConcept C159110408 @default.
• W3024348737 hasConcept C162853370 @default.
• W3024348737 hasConcept C190248442 @default.
• W3024348737 hasConcept C2426938 @default.
• W3024348737 hasConcept C3018553135 @default.
• W3024348737 hasConcept C36289849 @default.
• W3024348737 hasConcept C512399662 @default.
• W3024348737 hasConcept C56995899 @default.
• W3024348737 hasConcept C71924100 @default.
• W3024348737 hasConcept C74196892 @default.
• W3024348737 hasConceptScore W3024348737C104863432 @default.
• W3024348737 hasConceptScore W3024348737C126322002 @default.
• W3024348737 hasConceptScore W3024348737C144024400 @default.
• W3024348737 hasConceptScore W3024348737C144133560 @default.
• W3024348737 hasConceptScore W3024348737C159110408 @default.
• W3024348737 hasConceptScore W3024348737C162853370 @default.
• W3024348737 hasConceptScore W3024348737C190248442 @default.
• W3024348737 hasConceptScore W3024348737C2426938 @default.
• W3024348737 hasConceptScore W3024348737C3018553135 @default.
• W3024348737 hasConceptScore W3024348737C36289849 @default.
• W3024348737 hasConceptScore W3024348737C512399662 @default.
• W3024348737 hasConceptScore W3024348737C56995899 @default.
• W3024348737 hasConceptScore W3024348737C71924100 @default.
• W3024348737 hasConceptScore W3024348737C74196892 @default.
• W3024348737 hasFunder F4320323175 @default.
• W3024348737 hasIssue "3" @default.
• W3024348737 hasLocation W30243487371 @default.
• W3024348737 hasOpenAccess W3024348737 @default.
• W3024348737 hasPrimaryLocation W30243487371 @default.
• W3024348737 hasRelatedWork W1792828491 @default.

• next